Papers

11

Total Citations

127

H-Index

6

About

Dr. Thenappan Chandrasekar is a leading urologic oncologist and robotic surgeon whose research focuses on advancing minimally invasive surgical techniques for prostate, kidney, and bladder cancers. His seminal work includes a landmark 2010 study comparing lymph node yields in robot-assisted versus open radical prostatectomy, which helped validate the oncologic adequacy of robotic approaches. With over 30 citations, his 2022 investigation into individualized 3D-printed models for robotic partial nephrectomies demonstrates his commitment to integrating cutting-edge technology for improved surgical planning and patient education. Dr. Chandrasekar has also made significant contributions to pediatric urology, analyzing urinary diversion practices in over 2,000 pediatric pyeloplasties. His research portfolio extends to addressing complex clinical challenges, including robotic surgery for renal cell carcinoma with inferior vena cava thrombus and comparative outcomes of robotic versus open radical cystectomy. Notably, he has championed opioid stewardship in urologic surgery, leading collaborative efforts to reduce narcotic prescriptions after prostatectomy. Through his systematic reviews and population-based analyses, Dr. Chandrasekar continues to shape evidence-based practice in robotic urologic surgery, with his work cited extensively by peers worldwide.

Research Focus

Key Achievements

6
H-Index
11
Papers
127
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of lymph node yield in robot‐assisted laparoscopic prostatectomy with that in open radical retropubic prostatectomy
32 citations · 2010
📈 Most Prolific Year: 2020 (4 Papers)
🤝 Key Collaborators: 62
🏛 Institutions: Thomas Jefferson University, University of California, Davis, University Health Network

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago